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Introduction
MAS occurs frequently in patients with active sJIA and
because of the similarities with HLH is classified among
secondary HLH. Systemic juvenile idiopathic arthritis
(s-JIA) is characterized by high levels of Interleukin-6
(IL-6). Impairment of natural killer (NK) cell function and
decrease perforin expression have also been reported in
sJIA.
Objectives
Aim of this study was to evaluate the effect of IL-6 on
NK cell cytotoxic function.
Methods
Following in vivo treatment with poly(I:C), splenic NK cell
cytotoxic activity from wild tipe (WT) or IL-6 transgenic
(IL-6TG) mice was evaluated using the chromium51
release assay. NK cell number, perforin, GranzymeB,
CD69 and CD107a expression were evaluated by flow
cytometric analysis. Human polyclonal NK cells were
expanded from peripheral blood mononuclear cells
(PBMCs) in co-cultures with the feeder cell line
RPMI8866 in the presence of tocilizumab, an IL-6 recep-
tor blocker, or isotype control. IL-6 production in the
supernatants of human polyclonal NK cells was measured
by ELISA. PBMCs from healthy donors were treated with
IL-6. NK cell cytotoxic activity, Perforin and CD107a
expression were evaluated as above.
Results
Following poly(I:C) administration, in vivo generation of
splenic NK cell cytotoxicity was markedly reduced in
IL-6TG compared to WT mice. In IL6TG mice number
of NK cells, number of CD69+ NK cells and degranula-
tion were comparable to WT mice. Defective expression
of both perforin and GranzymeB were found in NK cells
from IL-6TG mice. High levels of IL-6 were found in
the supernatants of human polyclonal NK cells.
Neutralizing IL-6 with tocilizumab in co-cultures of
human PBMCs increased human NK cell cytotoxicity
and perforin expression. Addition of IL-6 to human
PBMCs decreased perforin expression in NK cells.
Conclusion
Both in vivo in mice and in vitro in humans, IL-6
inhibits NK cytotoxicity down-regulating perforin
expression. In patients with prominent inflammatory
response, such as JIA, high levels of IL-6 may contribute
to the induction of MAS also by inhibiting cytotoxicity
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